Finerenone's Role in Heart Failure from ESC Congress Data
Sep 02, 04:25 PM
Live from ESC Congress 2024!
In this edition of Don’t Miss a Beat, Stephen Greene, MD, an advanced heart failure specialist at Duke University School of Medicine, discusses the prospect of finerenone in treatment algorithms for heart failure with Muthiah Vaduganathan, MD, MPH, codirector of the Center for Cardiometabolic Implementation Science of Brigham and Women’s Hospital, based on data from the meeting, including FINEARTS-HF, FINE-HEART, and an analysis on MRA use in heart failure.
Chapters
00:00 - Welcome and Introduction
01:18 - FINEARTS-HF Study Design and Patient Population
03:04 - Inclusion of Hospitalized Patients
04:43 - Primary and Secondary Endpoints
05:56 - Challenges in Achieving Statistical Significance
07:39 - Health Status Improvement and Additional Analyses
10:01 - Combination Therapy and Future Trials
12:20 - Hyperkalemia and Steroidal vs. Non-Steroidal MRAs
15:30 - Conclusion and Acknowledgments
In this edition of Don’t Miss a Beat, Stephen Greene, MD, an advanced heart failure specialist at Duke University School of Medicine, discusses the prospect of finerenone in treatment algorithms for heart failure with Muthiah Vaduganathan, MD, MPH, codirector of the Center for Cardiometabolic Implementation Science of Brigham and Women’s Hospital, based on data from the meeting, including FINEARTS-HF, FINE-HEART, and an analysis on MRA use in heart failure.
Chapters
00:00 - Welcome and Introduction
01:18 - FINEARTS-HF Study Design and Patient Population
03:04 - Inclusion of Hospitalized Patients
04:43 - Primary and Secondary Endpoints
05:56 - Challenges in Achieving Statistical Significance
07:39 - Health Status Improvement and Additional Analyses
10:01 - Combination Therapy and Future Trials
12:20 - Hyperkalemia and Steroidal vs. Non-Steroidal MRAs
15:30 - Conclusion and Acknowledgments